NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

眼科設備市場:按產品功能-全球機會分析和行業預測(2020-2027)

Ophthalmic Devices Market by Product Function : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 980770
出版日期 內容資訊 英文 205 Pages
商品交期: 2-3個工作天內
價格
眼科設備市場:按產品功能-全球機會分析和行業預測(2020-2027) Ophthalmic Devices Market by Product Function : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年11月30日內容資訊: 英文 205 Pages
簡介

2019年,眼科設備的全球市場達到534.28億美元。從2020年到2027年,該市場的複合年增長率預計為4.2%,到2027年將達到66,719,300,000美元。

眼科是涉及結構,功能和各種眼疾的醫學分支。眼科設備是設計用於診斷,手術和視力矯正的醫療設備。它涵蓋了廣泛的設計類型和應用,例如隱形眼鏡,眼鏡,人工晶狀體,植入物,雷射光,診斷設備和手術器械。由於包括青光眼,白內障和其他與視覺有關的疾病在內的各種眼科疾病的流行,這些裝置變得越來越重要並被採用。

全球眼科設備市場的增長主要是由於視力障礙的發生率增加,眼內鏡片(IOL)等眼科設備的技術進步以及有關眼科設備使用的員工技能。在日益重視客戶培訓和教育建設的推動下。另外,與視覺障礙相關的新設備的開發方面的越來越多的研發以及對眼科中使用的設備的認識的提高也為全球市場的增長做出了貢獻。但是,人們對與眼有關的疾病的瞭解不足以及缺乏熟練的專業人員都將阻礙市場的增長。同時,由於中國和印度等新興國家的醫療基礎設施改善,它們具有較高的增長潛力,預計在預測期內將為市場擴展提供有益的機會。

該報告調查了眼科設備市場,提供了市場概況,按產品功能和地區劃分的趨勢以及進入市場的公司的概況。

目錄

第1章簡介

第2章執行摘要

第3章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要成功策略
    • 2019年頂級玩家排名
    • 塑造全球眼科設備市場的主要力量
  • 市場動態
    • 促進因素
      • 全世界與眼有關的疾病患病率上升
      • 眼科技術的飛速發展
      • 由於意識增強,對客戶培訓和教育的關注度提高
      • 全球數位設備的廣泛採用
    • 抑制因素
      • 對眼睛相關疾病的認識不足
      • 缺乏熟練的專業人員
    • 市場機會
      • 眼科設備製造商在新興國家的潛在增長機會
  • 政府法規
    • FDA
    • CE標誌
    • 製藥和醫療設備組織以及厚生勞動省(MHLW)
  • COVID-19對眼科設備市場的影響

第4章眼科設備市場:按產品功能

  • 概述
    • 市場規模和預測:按地區
  • 手術器械
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按地區
    • 屈光手術異常
      • 市場規模和預測
      • 市場規模和預測:按類型
      • Exima和Femto Second Laser
      • 市場規模和預測
      • 角膜刀
      • 市場規模和預測
    • 青光眼手術器械
      • 市場規模和預測
      • 市場規模和預測:按類型
      • 植入物和支架
      • 市場規模和預測
      • 青光眼引流器
      • 市場規模和預測
      • 青光眼激光裝置
      • 市場規模和預測
    • 白內障手術器械
      • 市場規模和預測
      • 市場規模和預測:按類型
      • 人工晶狀體
      • 市場規模和預測
      • 粘彈性
      • 市場規模和預測
      • 晶體超聲乳化抽吸系統
      • 市場規模和預測
    • 玻璃體視網膜手術器械
      • 市場規模和預測
      • 市場規模和預測:按類型
      • 玻璃體切除機和玻璃體切除包
      • 市場規模和預測
      • 光凝雷射光
      • 市場規模和預測
      • 照明裝置
      • 市場規模和預測
  • 診斷設備
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按地區
    • 折射望遠鏡
      • 市場規模和預測
    • 角膜地形圖系統
      • 市場規模和預測
    • 視網膜超聲系統
      • 市場規模和預測
    • 眼底照相機
      • 市場規模和預測
    • 檢眼鏡
      • 市場規模和預測
    • 光學相干胃成像系統
      • 市場規模和預測
    • 外圍長度
      • 市場規模和預測
    • 小間隙燈
      • 市場規模和預測
    • 眼壓計
      • 市場規模和預測
  • 視力保健設備
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按地區
    • 隱形眼鏡
      • 市場規模和預測
    • 眼鏡鏡片
      • 市場規模和預測

第5章眼科設備市場:按地區

  • 概述
    • 市場規模和預測
  • 北美
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按產品功能
    • 市場規模和預測:按地區
    • 美國
      • 市場規模和預測:按產品功能
    • 加拿大
      • 市場規模和預測:按產品功能
    • 墨西哥
      • 市場規模和預測:按產品功能
  • 歐洲
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按產品功能
    • 市場規模和預測:按地區
    • 德國
      • 市場規模和預測:按產品功能
    • 法國
      • 市場規模和預測:按產品功能
    • 英國
      • 市場規模和預測:按產品功能
    • 意大利
      • 市場規模和預測:按產品功能
    • 西班牙
      • 市場規模和預測:按產品功能
    • 其他
      • 市場規模和預測:按產品功能
  • 亞太地區
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按產品功能
    • 市場規模和預測:按地區
    • 日本
      • 市場規模和預測:按產品功能
    • 中國
      • 市場規模和預測:按產品功能
    • 澳大利亞市場規模和預測
      • 市場規模和預測:按產品功能
    • 印度
      • 市場規模和預測:按產品功能
    • 其他亞太地區
      • 市場規模和預測:按產品功能
  • 拉美
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按產品功能
    • 市場規模和預測:按地區
    • 巴西
      • 市場規模和預測:按產品功能
    • 沙特阿拉伯市場規模和預測
      • 市場規模和預測:按產品功能
    • 南非
      • 市場規模和預測:按產品功能
    • 其他
      • 市場規模和預測:按產品功能

第6章公司簡介

  • CARL ZEISS MEDITEC AG
  • ESSILOR INTERNATIONAL S.A.
  • HAAG-STREIT HOLDING AG
  • HOYA CORPORATION
  • JOHNSON & JOHNSON
  • NIDEK CO., LTD.
  • NOVARTIS AG (ALCON-A DIVISION OF NOVARTIS)
  • TOPCON CORPORATION
  • BAUSCH HEALTH COMPANIES INC.
  • ZIEMER OPHTHALMIC SYSTEMS AG
  • 合併/收購(M&A)活動清單
目錄
Product Code: A01716

Title:
Ophthalmic Devices Market by Product Function [Surgical Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices) Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometer), and Vision Care Devices (Contact Lenses and Spectacles)]: Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global ophthalmic devices market was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.

Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. They cover a wide range of design types and applications such as contact lenses, glasses, intraocular lenses, implants, lasers, diagnostics, and surgical instruments. These devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.

The growth of the global ophthalmic devices market is majorly driven by rise In incidence of vision disorders, technological advancements in ophthalmic devices such as intraocular lenses (IOLs), and increase in focus on customer training & education for use of ophthalmic devices, which would help in building the staff skills. In addition, increase in R&D developments for novel devices development related to vision error and surge in awareness related to devices used in ophthalmology contribute toward the growth of the global market. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. On the contrary, emerging countries such as China and India possess high growth potential, owing to improvement in healthcare infrastructure in these countries, which is anticipated to offer remunerative opportunities for the expansion of the market during the forecast period.

Depending on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices.

The ophthalmic diagnostic devices segment is subsegmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer.

The vision care devices segment is bifurcated into contact lenses and spectacle lenses

On a regional level, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share; however, Asia-Pacific is anticipated to grow with the highest CAGR of 4.6% during the forecast period.

The global ophthalmology devices market is highly competitive in nature, as major players have focused on the development and launch of innovative products to garner maximum share in the competitive market. The key players operating in the market include Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, HOYA Corporation, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry include Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global ophthalmic devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ophthalmic devices market growth.

KEY MARKET SEGMENTS

By Product Function

  • Ophthalmic Surgical Devices
  • Refractive Error Surgical Devices
  • Glaucoma Surgical Devices
  • Cataract Surgery Devices
  • Vitreoretinal Surgical Devices
  • Ophthalmic Diagnostic Devices
  • Refractors
  • Corneal Topography Systems
  • Retinal Ultrasound Systems
  • Fundus Camera
  • Ophthalmoscopes
  • Optical Coherence Tomography Systems
  • Perimeters
  • Slit Lamps
  • Tonometer's
  • Ophthalmic Vision Care Devices
  • Contact Lenses
  • Spectacle Lenses

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • List of key players profiled in the report
  • Novartis AG
  • Carl Zeiss Meditec AG
  • Essilor International S.A.
  • HAAG-Streit Holding AG
  • Johnson & Johnson
  • Nidek Co., Ltd.
  • Topcon Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Ophthalmic Systems AG
  • Hoya Corporation

List of other players in the value chain (profiles not included in the report):

  • Sonomed Escalon
  • Gulden Ophthalmics
  • FCI Ophthalmics
  • Glaukos Corporation
  • STAAR Surgical GE Healthcare

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
    • 1.1.1.Key benefits for stakeholders
    • 1.1.2.Key market segments
  • 1.2.Research methodology
    • 1.2.1.Secondary research
    • 1.2.2.Primary research
    • 1.2.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top winning strategies
    • 3.2.2.Top player positioning, 2019
    • 3.2.3.Key forces shaping the global ophthalmic devices market
  • 3.3.Market dynamics
    • 3.3.1.Drivers
      • 3.3.1.1.Rise in prevalence of eye-related diseases worldwide
      • 3.3.1.2.Rapid technological advancements in ophthalmic
      • 3.3.1.3.Increase in focus on customer training and education along with awareness
      • 3.3.1.4.High adoption of digital devices worldwide
    • 3.3.2.Restraints
      • 3.3.2.1.Low awareness about eye-related diseases
      • 3.3.2.2.Dearth of skilled professionals
    • 3.3.3.Opportunities
      • 3.3.3.1.Potential growth opportunities in emerging nations for ophthalmic devices manufacturers
  • 3.4.Government regulations
    • 3.4.1.FDA
    • 3.4.2.CE Mark
    • 3.4.3.Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)
  • 3.5.Impact of COVID-19 on ophthalmic devices market

CHAPTER 4:OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

  • 4.1.Overview
    • 4.1.1.Market size and forecast, by region
  • 4.2.Surgical devices
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Refractive error surgical devices
      • 4.2.3.1.Market size and forecast
      • 4.2.3.2.Market size and forecast, by type
      • 4.2.3.3.Excimers and femtosecond lasers
      • 4.2.3.4.Market size and forecast
      • 4.2.3.5.Microkeratomes
      • 4.2.3.6.Market size and forecast
    • 4.2.4.Glaucoma surgical devices
      • 4.2.4.1.Market size and forecast
      • 4.2.4.2.Market size and forecast, by type
      • 4.2.4.3.Implants and stents
      • 4.2.4.4.Market size and forecast
      • 4.2.4.5.Glaucoma drainage devices
      • 4.2.4.6.Market size and forecast
      • 4.2.4.7.Glaucoma laser devices
      • 4.2.4.8.Market size and forecast
    • 4.2.5.Cataract surgical devices
      • 4.2.5.1.Market size and forecast
      • 4.2.5.2.Market size and forecast, by type
      • 4.2.5.3.Intraocular lenses
      • 4.2.5.4.Market size and forecast
      • 4.2.5.5.Viscoelastic
      • 4.2.5.6.Market size and forecast
      • 4.2.5.7.Phacoemulsification systems
      • 4.2.5.8.Market size and forecast
    • 4.2.6.Vitreoretinal surgical devices
      • 4.2.6.1.Market size and forecast
      • 4.2.6.2.Market size and forecast, by type
      • 4.2.6.3.Vitrectomy machines and vitrectomy packs
      • 4.2.6.4.Market size and forecast
      • 4.2.6.5.Photocoagulation lasers
      • 4.2.6.6.Market size and forecast
      • 4.2.6.7.Illumination devices
      • 4.2.6.8.Market size and forecast
  • 4.3.Diagnostic devices
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Refractors
      • 4.3.3.1.Market size and forecast
    • 4.3.4.Corneal topography systems
      • 4.3.4.1.Market size and forecast
    • 4.3.5.Retinal ultrasound systems
      • 4.3.5.1.Market size and forecast
    • 4.3.6.Fundus camera
      • 4.3.6.1.Market size and forecast
    • 4.3.7.Ophthalmoscopes
      • 4.3.7.1.Market size and forecast
    • 4.3.8.Optical coherence tomography systems
      • 4.3.8.1.Market size and forecast
    • 4.3.9.Perimeters
      • 4.3.9.1.Market size and forecast
    • 4.3.10.Slit lamps
      • 4.3.10.1.Market size and forecast
    • 4.3.11.Tonometer
      • 4.3.11.1.Market size and forecast
  • 4.4.Vision care devices
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Contact lenses
      • 4.4.3.1.Market size and forecast
    • 4.4.4.Spectacle lenses
      • 4.4.4.1.Market size and forecast

CHAPTER 5:OPHTHALMIC DEVICES MARKET, BY REGION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.North America
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast, by product function
    • 5.2.3.Market size and forecast, by region
    • 5.2.4.U.S.
      • 5.2.4.1.Market size and forecast, by product function
    • 5.2.5.Canada
      • 5.2.5.1.Market size and forecast, by product function
    • 5.2.6.Mexico
      • 5.2.6.1.Market size and forecast, by product function
  • 5.3.Europe
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast, by product function
    • 5.3.3.Market size and forecast, by region
    • 5.3.4.Germany
      • 5.3.4.1.Market size and forecast, by product function
    • 5.3.5.France
      • 5.3.5.1.Market size and forecast, by product function
    • 5.3.6.UK
      • 5.3.6.1.Market size and forecast, by product function
    • 5.3.7.Italy
      • 5.3.7.1.Market size and forecast, by product function
    • 5.3.8.Spain
      • 5.3.8.1.Market size and forecast, by product function
    • 5.3.9.Rest of the Europe
      • 5.3.9.1.Market size and forecast, by product function
  • 5.4.Asia-Pacific
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast, by product function
    • 5.4.3.Market size and forecast, by region
    • 5.4.4.Japan
      • 5.4.4.1.Market size and forecast, by product function
    • 5.4.5.China
      • 5.4.5.1.Market size and forecast, by product function
    • 5.4.6.Australia market size and forecast
      • 5.4.6.1.Market size and forecast, by product function
    • 5.4.7.India
      • 5.4.7.1.Market size and forecast, by product function
    • 5.4.8.Rest of Asia-Pacific
      • 5.4.8.1.Market size and forecast, by product function
  • 5.5.LAMEA
    • 5.5.1.Key market trends, growth factors, and opportunities
    • 5.5.2.Market size and forecast, by product function
    • 5.5.3.Market size and forecast, by region
    • 5.5.4.Brazil
      • 5.5.4.1.Market size and forecast, by product function
    • 5.5.5.Saudi Arabia market size and forecast
      • 5.5.5.1.Market size and forecast, by product function
    • 5.5.6.South Africa
      • 5.5.6.1.Market size and forecast, by product function
    • 5.5.7.Rest of LAMEA
      • 5.5.7.1.Market size and forecast, by product function

CHAPTER 6:COMPANY PROFILES

  • 6.1.CARL ZEISS MEDITEC AG
    • 6.1.1.Company overview
    • 6.1.2.Company snapshot
    • 6.1.3.Operating business segments
    • 6.1.4.Product portfolio
    • 6.1.5.Business performance
  • 6.2.ESSILOR INTERNATIONAL S.A.
    • 6.2.1.Company overview
    • 6.2.2.Company snapshot
    • 6.2.3.Operating business segments
    • 6.2.4.Product portfolio
    • 6.2.5.Business performance
    • 6.2.6.Key strategic moves and developments
  • 6.3.HAAG-STREIT HOLDING AG
    • 6.3.1.Company overview
    • 6.3.2.Company snapshot
    • 6.3.3.Operating business segments
  • 6.4.HOYA CORPORATION
    • 6.4.1.Company overview
    • 6.4.2.Company snapshot
    • 6.4.3.Operating business segments
    • 6.4.4.Business performance
    • 6.4.5.Key strategic moves and developments
  • 6.5.JOHNSON & JOHNSON
    • 6.5.1.Company overview
    • 6.5.2.Company snapshot
    • 6.5.3.Operating business segments
    • 6.5.4.Product portfolio
    • 6.5.5.Business performance
    • 6.5.6.Key strategic moves and developments
  • 6.6.NIDEK CO., LTD.
    • 6.6.1.Company overview
    • 6.6.2.Company snapshot
    • 6.6.3.Operating business segments
    • 6.6.4.Key strategic moves & developments
  • 6.7.NOVARTIS AG (ALCON-A DIVISION OF NOVARTIS)
    • 6.7.1.Company overview
    • 6.7.2.Company snapshot
    • 6.7.3.Operating business segments
    • 6.7.4.Product portfolio
    • 6.7.5.Business performance
  • 6.8.TOPCON CORPORATION
    • 6.8.1.Company overview
    • 6.8.2.Company snapshot
    • 6.8.3.Operating business segments
    • 6.8.4.Product portfolio
    • 6.8.5.Business performance
  • 6.9.BAUSCH HEALTH COMPANIES INC.
    • 6.9.1.Company overview
    • 6.9.2.Company snapshot
    • 6.9.3.Operating business segments
    • 6.9.4.Product portfolio
    • 6.9.5.Business performance
  • 6.10.ZIEMER OPHTHALMIC SYSTEMS AG
    • 6.10.1.Company overview
    • 6.10.2.Company snapshot
    • 6.10.3.Product portfolio
  • 6.11.List of mergers and acquisitions (M&A) activities

LIST OF TABLES

  • TABLE 01.GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 02.GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03.GLOBAL REFRACTIVE ERROR SURGERY DEVICES MARKET, BY TYPE 2019-2027
  • TABLE 04.GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE 2019-2027
  • TABLE 05.GLOBAL CATARACT SURGERY DEVICES MARKET, BY TYPE 2019-2027
  • TABLE 06.GLOBAL VITREORETINAL EYE SURGERY MARKET, BY TYPE 2019-2027
  • TABLE 07.OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.OPHTHALMIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 11.NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 12.U.S. OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 13.CANADA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 14.MEXICO OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 15.EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 16.EUROPE OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 17.GERMANY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 18.FRANCE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 19.UK OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 20.ITALY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 21.SPAIN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 22.REST OF EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 23.ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 24.ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 25.JAPAN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 26.CHINA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 27.AUSTRALIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 28.INDIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 29.REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 30.LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 31.LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 32.BRAZIL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 33.SAUDI ARABIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 34.SOUTH AFRICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 35.REST OF LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 36.CARL ZEISS: COMPANY SNAPSHOT
  • TABLE 37.CARL ZEISS: OPERATING SEGMENTS
  • TABLE 38.CARL ZEISS: PRODUCT PORTFOLIO
  • TABLE 39.ESSILOR: COMPANY SNAPSHOT
  • TABLE 40.ESSILOR: OPERATING SEGMENTS
  • TABLE 41.ESSILOR: PRODUCT PORTFOLIO
  • TABLE 42.HAAG-STREIT: COMPANY SNAPSHOT
  • TABLE 43.HAAG-STREIT: OPERATING SEGMENTS
  • TABLE 44.HOYA: COMPANY SNAPSHOT
  • TABLE 45.HOYA: OPERATING SEGMENTS
  • TABLE 46.J&J: COMPANY SNAPSHOT
  • TABLE 47.J&J: OPERATING SEGMENTS
  • TABLE 48.J&J: PRODUCT PORTFOLIO
  • TABLE 49.NIDEK: COMPANY SNAPSHOT
  • TABLE 50.NIDEK: OPERATING SEGMENTS
  • TABLE 51.NOVARTIS: COMPANY SNAPSHOT
  • TABLE 52.NOVARTIS: OPERATING SEGMENTS
  • TABLE 53.NOVARTIS: PRODUCT PORTFOLIO
  • TABLE 54.TOPCON: COMPANY SNAPSHOT
  • TABLE 55.TOPCON: OPERATING SEGMENTS
  • TABLE 56.TOPCON: PRODUCT PORTFOLIO
  • TABLE 57.BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT
  • TABLE 58.BAUSCH HEALTH COMPANIES : OPERATING SEGMENTS
  • TABLE 59.BAUSCH HEALTH COMPANIES: PRODUCT PORTFOLIO
  • TABLE 60.ZEIMER: COMPANY SNAPSHOT
  • TABLE 61.ZIEMER: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL OPHTHALMIC DEVICES MARKET SEGMENTATION
  • FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2016-2020
  • FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2020 (%)
  • FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2016-2020
  • FIGURE 05.TOP PLAYER POSITIONING, 2019
  • FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.HIGH THREAT OF SUBSTITUTION
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE COMPETITVE RIVARLY
  • FIGURE 11.MARKET DYNAMICS FOR OPHTHALMIC DEVICES MARKET
  • FIGURE 12.GLOBAL REFRACTIVE ERROR SURGERY DEVICES MARKET, 2019-2027
  • FIGURE 13.GLOBAL EXCIMERS AND FEMTOSECOND LASERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 14.GLOBAL MICROKERATOMES MARKET, 2019-2027 ($MILLION)
  • FIGURE 15.GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, 2019-2027
  • FIGURE 16.GLOBAL IMPLANTS & STENTS MARKET, 2019-2027 ($MILLION)
  • FIGURE 17.GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 18.GLOBAL GLAUCOMA LASER DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 19.GLOBAL CATARACT SURGERY DEVICES MARKET, 2019-2027
  • FIGURE 20.GLOBAL INTRAOCULAR LENSES MARKET, BY TYPE 2019-2027
  • FIGURE 21.GLOBAL VISCOELASTICS MARKET, BY TYPE 2019-2027
  • FIGURE 22.GLOBAL PHACOEMULSIFICATION MARKET, BY TYPE 2019-2027
  • FIGURE 23.GLOBAL VITREORETINAL EYE SURGERY DEVICES MARKET, 2019-2027
  • FIGURE 24.GLOBAL VITRECTOMY MACHINES AND VITRECTOMY PACKS MARKET, BY TYPE 2019-2027
  • FIGURE 25.GLOBAL PHOTOCOAGULATION MARKET, 2019-2027
  • FIGURE 26.GLOBAL ILLUMINATIN DEVICES MARKET, 2019-2027
  • FIGURE 27.GLOBAL REFRACTORS MARKET, 2019-2027 ($MILLION)
  • FIGURE 28.GLOBAL CORNEAL TOPOGRAPHY SYSTEMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 29.GLOBAL RETINAL ULTRASOUND SYSTEMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 30.GLOBAL FUNDUS CAMERA MARKET, 2019-2027 ($MILLION)
  • FIGURE 31.GLOBAL OPHTHALMOSCOPES MARKET, 2019-2027 ($MILLION)
  • FIGURE 32.GLOBAL OPTICAL COHERANCE TOMPGRAPHY SYSTEMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 33.GLOBAL PERIMETERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 34.GLOBAL SLIT LAMPS MARKET, 2019-2027 ($MILLION)
  • FIGURE 35.GLOBAL TONOMETERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 36.GLOBAL CONTACT LENSES MARKET, 2019-2027 ($MILLION)
  • FIGURE 37.GLOBAL SPECTACLE LENSES MARKET, 2019-2027 ($MILLION)
  • FIGURE 38.U.S. OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 39.CANADA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 40.MEXICO OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 41.GERMANY OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 42.FRANCE OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 43.UK OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 44.ITALY OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 45.SPAIN OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 46.REST OF THE EUROPE OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 47.JAPAN OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 48.CHINA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 49.AUSTRALIA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 50.INDIA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 51.REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 52.BRAZIL OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 53.SAUDI ARABIA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 54.SOUTH AFRICA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 55.REST OF LAMEA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 56.CARL ZEISS: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 57.CARL ZEISS: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 58.CARL ZEISS: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 59.ESSILOR: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 60.ESSILOR: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 61.HOYA: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 62.HOYA: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 63.HOYA: REVENUE SAHRE FOR LIFE CARE SEGMENT, 2019 (%)
  • FIGURE 64.HOYA: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 65.J&J: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 66.J&J: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 67.J&J: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 68.NOVARTIS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 69.NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 70.NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 71.TOPCON: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 72.TOPCON: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 73.BAUSCH HEALTH COMPANIES : REVENUE, 2017-2019 ($MILLION)
  • FIGURE 74.BAUSCH HEALTH COMPANIES : REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 75.BAUSCH HEALTH COMPANIES: REVENUE SHARE BY REGION, 2019 (%)